Abstract:Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease, characterized by a decline in lung function. To date, the pathophysiologic mechanisms associated with lung dysfunction remain unclear, and no effective therapy has been identified to improve lung function. Methods In the present study, we used weighted gene co-expression network analysis (WGCNA) to identify key modules and hub genes associated with lung function in IPF. Three datasets, containing clinical information, were downloaded from Gene Expression Omnibus. WGCNA was performed on the GSE32537 dataset. Differentially expressed gene s (DEGs) between IPF patients and healthy controls were also identified to filter hub genes. The relationship between hub genes and lung function was then validated using the GSE47460 and GSE24206 datasets. Results The red module, containing 267 genes, was positively correlated with the St. George’s Respiratory Questionnaire score ( r = 0.37, p < 0.001) and negatively correlated with the percent predicted forced vital capacity (FVC% predicted) ( r = − 0.46, p < 0.001) and the percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) ( r = − 0.42, p < 0.001). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis suggested that the genes in the red module were primarily involved in inflammation and immune pathways. Based on Module Membership and Gene Significance, 32 candidate hub genes were selected in the red module to construct a protein-protein interaction network . Based on the identified DEGs and the degree of connectivity in the network, we identified three hub genes, including interleukin 6 ( IL6 ), suppressor of cytokine signaling-3 ( SOCS3 ), and serpin family E member 1 ( SERPINE1 ). In the GSE47460 dataset, Spearman correlation coefficients between Dlco% predicted and expression levels of IL6 , SERPINE1 , SOCS3 were –0.32, –0.41, and –0.46, respectively. Spearman correlation coefficients between FVC% predicted and expression levels of IL6 , SERPINE1 , SOCS3 were –0.29, –0.33, and –0.27, respectively. In the GSE24206 dataset, all three hub genes were upregulated in patients with advanced IPF. Conclusion We identified three hub genes that negatively correlated with the lung function of IPF patients. Our results provide insights into the pathogenesis underlying the progressive disruption of lung function, and the identified hub genes may serve as biomarkers and potential therapeutictargets for the treatment of IPF patients.

Identification of the Key Genes in Chronic Obstructive Pulmonary Disease by Weighted Gene Co-Expression Network Analysis.

Identification of Susceptible Genes for Chronic Obstructive Pulmonary Disease with Lung Adenocarcinoma by Weighted Gene Co-Expression Network Analysis

Identification of Hub Genes and Key Pathways in the Emphysema Phenotype of COPD

Prioritizing Chronic Obstructive Pulmonary Disease (COPD) Candidate Genes in COPD-related Networks

Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis

Identification of immune-related hub genes in chronic obstructive pulmonary disease

Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis

Identification of Genes Related to Endoplasmic Reticulum Stress (ERS) in Chronic Obstructive Pulmonary Disease (COPD) and Clinical Validation

Analysis of Protein-Protein Interaction Network in Chronic Obstructive Pulmonary Disease.

Analysis of network expression and immune infiltration of disulfidptosis‐related genes in chronic obstructive pulmonary disease

Immune Characteristics Analysis and Transcriptional Regulation Prediction Based on Gene Signatures of Chronic Obstructive Pulmonary Disease

Identification of Immune-Related Gene Signatures for Chronic Obstructive Pulmonary Disease with Metabolic Syndrome: Evidence from Integrated Bulk and Single-Cell RNA Sequencing Data.

Identifying targets for COPD treatment through gene expression analyses.

Identification of novel biomarkers related to neutrophilic inflammation in COPD

Identification of related-genes of T cells in lung tissue of chronic obstructive pulmonary disease based on bioinformatics and experimental validation

Identifying Mirna Modules and Related Pathways of Chronic Obstructive Pulmonary Disease Associated Emphysema by Weighted Gene Co-Expression Network Analysis

A Signature for Smoking Status of Coronary Heart Disease Patients through Weighted Gene Coexpression Network Analysis

Identification of key modules and hub genes associated with lung function in idiopathic pulmonary fibrosis

Differential Coexpression Networks in Bronchiolitis and Emphysema Phenotypes Reveal Heterogeneous Mechanisms of Chronic Obstructive Pulmonary Disease

Candidate Gene Prioritization for Chronic Obstructive Pulmonary Disease Using Expression Information in Protein–protein Interaction Networks

Identification of Key Genes and Regulatory Networks Involved in the Comorbidity of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease